Eva Roblegg
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 34
- Advanced Drug Delivery Systems 30
- Advancements in Transdermal Drug Delivery 15
-
- Nanoparticles: synthesis and applications 20
- Crystallization and Solubility Studies 10
- Co-authors
- Eleonore Fröhlich (40 shared papers)Claudia Meindl (18 shared papers)Andreas Zimmer (23 shared papers)Johannes Khinast (27 shared papers)Gerd Leitinger (24 shared papers)Thomas R. Pieber (6 shared papers)Birgit Johanna Teubl (12 shared papers)Markus Absenger (6 shared papers)
In The Last Decade
Eva Roblegg
117 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 154
- Pharmaceutical Science 1.0k
- Biomaterials 525
- Pollution 407
- Health, Toxicology and Mutagenesis 290
- Materials Chemistry 999
Countries citing papers authored by Eva Roblegg
This map shows the geographic impact of Eva Roblegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Roblegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Roblegg more than expected).
Fields of papers citing papers by Eva Roblegg
This network shows the impact of papers produced by Eva Roblegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Roblegg. The network helps show where Eva Roblegg may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Roblegg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 213 | |
| 2 | 2013 | 193 | |
| 3 | 2014 | 137 | |
| 4 | 2019 | 109 | |
| 5 | 2012 | 108 | |
| 6 | 2013 | 105 | |
| 7 | 2012 | 100 | |
| 8 | 2009 | 96 | |
| 9 | 2009 | 95 | |
| 10 | 2012 | 92 | |
| 11 | 2011 | 88 | |
| 12 | 2013 | 81 | |
| 13 | 2020 | 81 | |
| 14 | 2016 | 64 | |
| 15 | 2012 | 61 | |
| 16 | 2014 | 55 | |
| 17 | 2015 | 55 | |
| 18 | 2017 | 54 | |
| 19 | 2011 | 53 | |
| 20 | 2011 | 53 |
About Eva Roblegg
Eva Roblegg is a scholar working on Pharmaceutical Science, Materials Chemistry, Biomedical Engineering, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 125 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (34 papers), Advanced Drug Delivery Systems (30 papers), Nanoparticles: synthesis and applications (20 papers), Advancements in Transdermal Drug Delivery (15 papers), Inhalation and Respiratory Drug Delivery (14 papers), Crystallization and Solubility Studies (10 papers), Microencapsulation and Drying Processes (8 papers) and Microplastics and Plastic Pollution (8 papers). The work is most often cited by research in Pharmaceutical Science (1.0k citations), Biomaterials (525 citations), Pollution (407 citations), Health, Toxicology and Mutagenesis (290 citations) and Materials Chemistry (999 citations). Eva Roblegg has collaborated with scholars based in Austria, Germany and Croatia. Frequent co-authors include Eleonore Fröhlich, Claudia Meindl, Andreas Zimmer, Johannes Khinast, Gerd Leitinger, Thomas R. Pieber, Birgit Johanna Teubl, Markus Absenger, Carolin Tetyczka and Davud Sirjani. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics, Pharmaceutics and Crystal Growth & Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.